Clinical Trial Update: AMP002 Phase III Contraceptive Study [Phase 3]

View source ↗

Summary

Phase III trial update for AMP002 contraception study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• AMP002

Snippet

Sponsor: Evofem Inc. | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2020-07-22